Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Paulden

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Health Promotion International|June 6, 2023
Housing for vulnerable populations-identifying system cost implications: an analytic literature reviewKrystyna Kongats, Mike Paulden, Roman Pabayo, et al.
Pharmacoeconomics|July 28, 2018
Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort ModelsAnthony J Hatswell, Ash Bullement, Andrew Briggs, et al.
The Canadian Journal of Urology|December 21, 2019
Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer settingJordan Hill, Mike Paulden, Christopher McCabe, et al.
Journal of the American Geriatrics Society|April 21, 2018
Turning High-Risk Individuals: An Economic Evaluation of Repositioning Frequency in Long-Term CarePetros Pechlivanoglou, Mike Paulden, Ba' Pham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Cost-effectiveness of the 21-gene assay for guiding adjuvant chemotherapy decisions in early breast cancerMike Paulden, Jacob Franek, Ba' Pham, et al.
Canadian Journal of Diabetes|February 12, 2022
Economic Evaluation of Sucrose Octasulfate Dressing for Treatment of Diabetic Foot Ulcers in Patients with Type 2 DiabetesJiabi Wen, Xuejing Jin, Fatima Al Sayah, et al.
Journal of Benefit-Cost Analysis|December 7, 2020
Accounting for Timing when Assessing Health-Related PoliciesKarl Claxton, Miqdad Asaria, Collins Chansa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 18, 2024
Author ReplyMike Paulden, Chris Sampson, James F O'Mahony, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 4, 2023
Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years GainedMike Paulden, Chris Sampson, James F O'Mahony, et al.
Pharmacoeconomics|February 6, 2010
Alitretinoin for severe chronic hand eczema: a NICE single technology appraisalMark Rodgers, Susan Griffin, Mike Paulden, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Health Promotion International|June 6, 2023
Housing for vulnerable populations-identifying system cost implications: an analytic literature reviewKrystyna Kongats, Mike Paulden, Roman Pabayo, et al.
Pharmacoeconomics|July 28, 2018
Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort ModelsAnthony J Hatswell, Ash Bullement, Andrew Briggs, et al.
The Canadian Journal of Urology|December 21, 2019
Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer settingJordan Hill, Mike Paulden, Christopher McCabe, et al.
Journal of the American Geriatrics Society|April 21, 2018
Turning High-Risk Individuals: An Economic Evaluation of Repositioning Frequency in Long-Term CarePetros Pechlivanoglou, Mike Paulden, Ba' Pham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Cost-effectiveness of the 21-gene assay for guiding adjuvant chemotherapy decisions in early breast cancerMike Paulden, Jacob Franek, Ba' Pham, et al.
Canadian Journal of Diabetes|February 12, 2022
Economic Evaluation of Sucrose Octasulfate Dressing for Treatment of Diabetic Foot Ulcers in Patients with Type 2 DiabetesJiabi Wen, Xuejing Jin, Fatima Al Sayah, et al.
Journal of Benefit-Cost Analysis|December 7, 2020
Accounting for Timing when Assessing Health-Related PoliciesKarl Claxton, Miqdad Asaria, Collins Chansa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 18, 2024
Author ReplyMike Paulden, Chris Sampson, James F O'Mahony, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 4, 2023
Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years GainedMike Paulden, Chris Sampson, James F O'Mahony, et al.
Pharmacoeconomics|February 6, 2010
Alitretinoin for severe chronic hand eczema: a NICE single technology appraisalMark Rodgers, Susan Griffin, Mike Paulden, et al.
Pageof 8